FDA made the right call on flibanserin
An article published on Feb. 29 in JAMA Internal Medicine and the associated editorial questioning the safety, efficacy, and approval of flibanserin are both factually inaccurate and misrepresent the...
Source: Clinical Psychiatry News - Category: Psychiatry Source Type: research
More News: Internal Medicine | Psychiatry